tiprankstipranks
Diamedica Therapeutics Inc (DMAC)
NASDAQ:DMAC
US Market

Diamedica Therapeutics (DMAC) Financial Statements

Compare
490 Followers

Diamedica Therapeutics Financial Overview

Diamedica Therapeutics's market cap is currently $163.71M. The company's EPS TTM is $-0.601; its P/E ratio is ―; Diamedica Therapeutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.18. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -30.00K$ -25.00K$ -24.00K$ -21.00K
Operating Income$ 0.00$ -21.27M$ -14.00M$ -13.65M$ -12.70M
EBITDA$ 0.00$ -19.31M$ -13.98M$ -13.62M$ -12.24M
Net Income$ -24.44M$ -19.38M$ -13.68M$ -13.59M$ -12.29M
Balance Sheet
Cash & Short-Term Investments$ 44.15M$ 52.90M$ 33.50M$ 45.11M$ 27.51M
Total Assets$ 46.34M$ 54.16M$ 34.40M$ 45.55M$ 28.09M
Total Debt$ 340.00K$ 400.00K$ 469.00K$ 52.00K$ 118.00K
Net Debt$ -2.69M$ -4.14M$ -4.26M$ -4.66M$ -7.29M
Total Liabilities$ 5.63M$ 3.10M$ 2.57M$ 1.53M$ 2.08M
Stockholders' Equity$ 40.72M$ 51.06M$ 31.83M$ 44.02M$ 26.01M
Cash Flow
Free Cash Flow$ -22.10M$ -18.75M$ -11.59M$ -12.27M$ -9.23M
Operating Cash Flow$ -22.08M$ -18.73M$ -11.51M$ -12.25M$ -9.19M
Investing Cash Flow$ 8.56M$ -18.30M$ 11.54M$ -20.54M$ -16.13M
Financing Cash Flow$ 11.99M$ 36.84M$ -6.00K$ 30.09K$ 28.84M
Currency in USD

Diamedica Therapeutics Earnings and Revenue History

Diamedica Therapeutics Debt to Assets

Diamedica Therapeutics Cash Flow

Diamedica Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis